Skip Nav Destination
Letter|
September 24, 2024
A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort
Clinical Trials & Observations
Yogen Saunthararajah
Yogen Saunthararajah
Cleveland Clinic, Cleveland, Ohio, United States
https://orcid.org/0000-0002-9757-1031
Search for other works by this author on:
Kira Gritsman
Kira Gritsman
Albert Einstein College of Medicine, Bronx, New York, United States
Search for other works by this author on:
Nishi Shah
Nishi Shah
Albert Einstein College of Medicine - Montefiore Medical Center, Bronx, New York, United States
Search for other works by this author on:
Lauren C Shapiro
Lauren C Shapiro
Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York, United States
Search for other works by this author on:
Brian A. Jonas
Brian A. Jonas
University of California Davis, Sacramento, California, United States
Search for other works by this author on:
Yang Shi
Yang Shi
Montefiore Medical Center, Bronx, New York, United States
Search for other works by this author on:
Marina Y. Konopleva
Marina Y. Konopleva
Albert Einstein College of Medicine, New York, New York, United States
Search for other works by this author on:
Amit Verma
Amit Verma
Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States
Search for other works by this author on:
Blood blood.2024025834.
Article history
Submitted:
June 28, 2024
Revision Received:
September 4, 2024
Accepted:
September 5, 2024
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal